| tested variables | cell types | cell types/ | TNM / | |
---|---|---|---|---|---|
 |  |  |  | inflamm. | infiltrate |
 |  | RR | 95% CI | RR | 95% CI |
local recurrence | peritumoral mast cells | Â | Â | Â | Â |
 | - none/few | 3.7 | 1.1 -12.8 | 1.9 | 0.5-7.1 |
 | -moderate | 1.3 | 0.4- 4.4 | 0.9 | 0.3-3.1 |
 | - many | 1.0 |  | 1.0 |  |
 | inflammatory infiltrate |  |  |  |  |
 | -none/few | - |  | 1.0 |  |
 | -extensive |  |  | 0.3 | 0.0-2.2 |
n = 148 | TNM | Â | Â | Â | Â |
33 events | - I/I I | - | Â | 1.0 | Â |
 | -III/IV |  |  | 2.4 | 0.9-6.1 |
distant | peritumoral mast cells | Â | Â | Â | Â |
metastases | - none/few | 4.5 | 1.6-12.2 | 2.5 | 1.2-5.8 |
 | - moderate | 1.1 | 0.4-2.9 | 0.9 | 0.3-2.3 |
 | - many | 1.0 |  | 1.0 |  |
 | intratumoral T cells (CD3) |  |  |  |  |
 | - none/few | 3.2 | 1.5-6.8 | 2.6 | 1.2-5.8 |
 | -moderate | 2.0 | 0.9-4.1 | 1.8 | 0.8-3.8 |
 | - many | 1.0 |  | 1.0 |  |
 | inflammatory infiltrate |  |  |  |  |
 | - none/few | - |  | 1.0 |  |
 | - extensive |  |  | 1.0 | 0.4-2.9 |
n = 159 | TNM | Â | Â | Â | Â |
65 events | -I/II | - | Â | 1.0 | Â |
 | -III/IV |  |  | 4.4 | 1.9-9.9 |
survival | peritumoral eosinophils | Â | Â | Â | Â |
 | - none/few | 3.6 | 1.5-8.7 | 3.0 | 1.2-7.2 |
 | -moderate | 2.8 | 1.2-6.6 | 2.1 | 0.9-5.1 |
 | - many | 1.0 |  | 1.0 |  |
 | peritumoral mast cells |  |  |  |  |
 | - none/few | 2.9 | 1.2-6.8 | 1.4 | 0.6-3.4 |
 | -moderate | 0.8 | 0.4-1.9 | 0.6 | 0.3-1.4 |
 | - many | 1.0 |  | 1.0 |  |
 | inflammatory infiltrate |  |  |  |  |
 | - none/few | - |  | 1.0 |  |
 | - extensive |  |  | 1.0 | 0.4-2.5 |
n = 136 | TNM | Â | Â | Â | Â |
59 events | - I/II | - | Â | 1.0 | Â |
 | - III/IV |  |  | 2.9 | 1.4-6.2 |